[Prostatic cytoplasmic androgen receptor in prostatic disease. II. Correlation between clinical response to hormonal therapy and change of R1881 receptor content in prostatic cancer during antiandrogenic therapy].
D000368:Aged; D000726:Androgen Antagonists / Q000627:therapeutic use*; D002369:Castration; D003593:Cytoplasm / Q000378:metabolism; D004963:Estrenes / Q000378:metabolism; D006801:Humans; D008297:Male; D015741:Metribolone; D011471:Prostatic Neoplasms / Q000032:analysis / Q000628:therapy*; D011485:Protein Binding; D011944:Receptors, Androgen / Q000032:analysis*; D011987:Receptors, Steroid / Q000032:analysis*; D045165:Testosterone Congeners / Q000378:metabolism
D000726:Androgen Antagonists; D004963:Estrenes; D011944:Receptors, Androgen; D011987:Receptors, Steroid; D045165:Testosterone Congeners; D015741:Metribolone